Viewing Study NCT00285259


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-01-10 @ 4:14 PM
Study NCT ID: NCT00285259
Status: COMPLETED
Last Update Posted: 2024-10-21
First Post: 2006-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Sponsor: Astellas Pharma Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-01-31
Start Date Type: ACTUAL
Primary Completion Date: 2009-11-30
Primary Completion Date Type: ACTUAL
Completion Date: 2010-11-30
Completion Date Type: ACTUAL
First Submit Date: 2006-01-30
First Submit QC Date: None
Study First Post Date: 2006-02-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2013-08-07
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2024-10-17
Last Update Post Date: 2024-10-21
Last Update Post Date Type: ACTUAL